MALT1 and inflammatory bowel disease: Hence, this study detected blood MALT1 expression in IBD patients at baseline, week (W) 4 and W12 after treatment, aiming to investigate the correlation of MALT1 with disease activity, inflammation indexes, and treatment response in IBD patients.